Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Cancer. 2017 Sep 26;123(23):4709–4719. doi: 10.1002/cncr.31035

Figure 3. One-way sensitivity analysis on age at HSIL diagnosis.

Figure 3

Figure shows the incremental cost-effectiveness ratio (95% CI) by HSIL age at diagnosis. The x-axis represents age at HSIL diagnosis and the y-axis represents willingness-to-pay threshold. Willingness-to-pay threshold of $100 000/QALY is considered economically acceptable.